Amoxicillin/Clavulanic Acid AB 500 mg - 125 mg film-coat. tabl. België - Engels - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amoxicillin/clavulanic acid ab 500 mg - 125 mg film-coat. tabl.

aurobindo sa-nv - amoxicillin trihydrate 573,4 mg - eq. amoxicillin 500 mg; clavulanic acid 125 mg - film-coated tablet - 500 mg - 125 mg - amoxicillin trihydrate 573.4 mg; clavulanic acid 125 mg - amoxicillin and enzyme inhibitor

Sandoz A/S Amoxicillin and Clavulanic Acid 1000mg/200mg Powder for Solution for Injection/Infusion Malta - Engels - Malta Medicines Authority

sandoz a/s amoxicillin and clavulanic acid 1000mg/200mg powder for solution for injection/infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - clavulanic acid, amoxicillin - powder for solution for infusion or injection - clavulanic acid 200 mg amoxicillin 1000 mg - antibacterials for systemic use

Cylanic 500  mg + 125 mg tablets for dogs Ierland - Engels - HPRA (Health Products Regulatory Authority)

cylanic 500 mg + 125 mg tablets for dogs

livisto int'l, s.l. - amoxicillin trihydrate; potassium clavulanate - tablet - 500/125 mg/tablet - amoxicillin and enzyme inhibitor

AMCLAMED 312.5MG DRY POWDER FOR SUSPENSION Powder For Oral Suspension Kenia - Engels - Pharmacy and Poisons Board

amclamed 312.5mg dry powder for suspension powder for oral suspension

medisel kenya limited p.o box 540-01000 thika - amoxicillin trihydrate & potassium clavulanate - powder for oral suspension - amoxicillin 250 mg & clavulanic acid 62.5 - amoxicillin and enzyme inhibitor

JUROCLAV 500 BROAD SPECTRUM ANTIBIOTIC TABLETS Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

juroclav 500 broad spectrum antibiotic tablets

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 400.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 100.0 mg/tb - antibiotic & related - calf | dog | beef calf | bitch | bovine | calf - poddy | calf - preweaning | calf - sucker | castrate | dairy calf | neonatal ca - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria

JUROCLAV 250 BROAD SPECTRUM ANTIBIOTIC TABLETS Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

juroclav 250 broad spectrum antibiotic tablets

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 200.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 50.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria

JUROCLAV 50 BROAD SPECTRUM ANTIBIOTIC TABLETS Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

juroclav 50 broad spectrum antibiotic tablets

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 40.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 10.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Amoxicillin Actavis Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

amoxicillin actavis

actavis new zealand limited - amoxicillin trihydrate 30.3 mg/ml equivalent to 25 mg/ml amoxicillin, on reconstitution;   - powder for oral suspension - 125 mg/5ml - active: amoxicillin trihydrate 30.3 mg/ml equivalent to 25 mg/ml amoxicillin, on reconstitution   excipient: carmellose sodium citric acid colloidal silicon dioxide erythrosine essence btm dm 7020a purified talc sodium benzoate sucrose - amoxicillin is indicated for the treatment of infections due to susceptible organisms. amoxicillin may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be determined. amoxicillin may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

Amoxicillin Actavis Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

amoxicillin actavis

actavis new zealand limited - amoxicillin trihydrate 60.26 mg/ml equivalent to 50 mg/ml amoxicillin, on reconstitution;   - powder for oral suspension - 250 mg/5ml - active: amoxicillin trihydrate 60.26 mg/ml equivalent to 50 mg/ml amoxicillin, on reconstitution   excipient: carmellose sodium citric acid colloidal silicon dioxide erythrosine essence btm dm 7020a purified talc sodium benzoate sucrose - amoxicillin is indicated for the treatment of infections due to susceptible organisms. amoxicillin may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be determined. amoxicillin may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis.

AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

amoxyclav b&b 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack

micro labs pty ltd - potassium clavulanate, quantity: 151.917 mg; amoxicillin trihydrate, quantity: 1004.31 mg - tablet, film coated - excipient ingredients: isopropyl alcohol; sodium starch glycollate; dichloromethane; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; propylene glycol; purified talc; ethylcellulose - amoxyclav b&b 875/125 tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (complicated and uncomplicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis.,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infections.,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets preparations should not require the addition of another antibiotic due to the amoxicillin content of these products.